Clinical trials
Every registered trial of Semaglutide
755 studies, 259 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Semaglutide has been studied in people a great deal.
- 755 registered studies in total.
- 259 are still enrolling people, so this is active research, not just history.
What kind of research
- 637 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 236,836 people took part in those.
- A further 118 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 268 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 190 have published results in the medical literature that anyone can read.
- The research spans 71 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 755 of 755 trials for Semaglutide.
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Ludwig-Maximilians - University of Munich
Severe Mental Illness · Depression / Major Depressive Disorder · Bipolar Disorder (BD) · Schizophrenia
GLP-1 RA for Stage 1 Type 1 Diabetes
Children's Hospital Medical Center, Cincinnati
Stage 1 Diabetes Mellitus, Type 1
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
Knut Mai
Obesity & Overweight · Weight Loss Maintenance
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
Lumos Pharma
Obesity & Overweight
Semaglutide for Low Back Pain
Washington University School of Medicine
Lower Back Pain · Obesity (BMI>30) · Chronic Lower Back Pain · glp1 Agonist
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Ministry of Health, Saudi Arabia
Type 1 Diabetes Mellitus
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
Hospital Universitari de Bellvitge
Endometrial Cancer · Endometrial Cancer Stage I · Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I · Atypical Endometrial Hyperplasia
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Miedziowe Centrum Zdrowia SA
Heart Failure With Preserved Ejection Fraction · Obesity · Diastolic Heart Failure · Pulmonary Hypertension
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
All India Institute of Medical Sciences, Bhubaneswar
Schizophrenia Disorder · Metabolic Syndrome · Antipsychotic-induced Weight Gain · Cardiovascular Risk
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
Vanderbilt University Medical Center
Type 2 Diabetes Mellitus (T2DM) · Sarcopenia · Obesity · Muscle Loss
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Insel Gruppe AG, University Hospital Bern
Adiposity · Fatty Liver · Alcohol Use Disorder
Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
University of Luebeck
Atrial Fibrillation (AF)
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
University of Minnesota
Obesity, Childhood
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Yale University
Alcohol Use Disorder (AUD) · Obesity (BMI Equal to or >30)
GLP-1s in Hip and Knee Arthroplasty
Nova Scotia Health Authority
Arthritis · Obesity & Overweight · GLP - 1
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Myocardial Metabolic Flux in Pulmonary Arterial Hypertension
Imperial College London
Pulmonary Arterial Hypertension
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
Population Health Research Institute
Ischemic Stroke
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Novo Nordisk A/S
Overweight · Obesity
Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
Tianjin Medical University
Type 2 Diabetes Mellitus (T2DM) · Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus
Semaglutide in Youth With Autism Spectrum Disorder
Children's Hospital Medical Center, Cincinnati
Autism Spectrum Disorder · Obesity
Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes
Western University, Canada
Type 2 Diabetes · Cognitive Decline in Older Adults
Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy
Vanderbilt University Medical Center
Duchenne Muscular Dystrophy (DMD)
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
Mayo Clinic
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Obesity & Overweight
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
Peking Union Medical College Hospital
Hypertriglyceridemia Induced Acute Pancreatitis · Recurrent Acute Pancreatitis · Pancreatitis Relapsing · Hypertriglyceridemia
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Kirby Institute
Methamphetamine Use Disorder
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
Carnot Laboratories
Obesity & Overweight
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
Carnot Laboratories
Type 2 Diabetes Mellitus (T2DM)
Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy
Phenomix Sciences
Obesity & Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Semaglutide as an add-on treatment to optimise glycaemic control in children and young people with type 1 diabetes (Smile T1D)
University of Birmingham
Type 1 diabetes
A Study of BGM0504 in Early T2DM With Obesity
BrightGene Bio-Medical Technology Co., Ltd.
Type 2 Diabetes (T2DM)
Salivary Function and Dental Changes During GLP-1 Therapy
Bilecik Seyh Edebali Universitesi
Obesity · Dental Erosion · Saliva Collection · Saliva Altered
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
D7261C00005
AstraZeneca AB
type 2 diabetes mellitus
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Novo Nordisk A/S
Overweight · Obesity
NN9932-8687
Novo Nordisk A/S
Overweight and obesity
Comparing Facial Aging Between Identical Twins With 3D Imaging
Ponsky Facial Aesthetics And Plastic Surgery, Llc
Facial Skin Aging · Facial Volume Loss · Wrinkle Appearance
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
Hospices Civils de Lyon
Obesity &Amp; Overweight · Digestive Disorders
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Novo Nordisk A/S
Overweight · Obesity
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Alain Dagher
Class I/II Obesity
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
The United Bio-Technology (Hengqin) Co., Ltd.
Type 2 Diabetes
R0126321A
Radboud universitair medisch centrum Stichting
Diabetic foot ulcer
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
VA Office of Research and Development
Alcohol Use Disorder
NN9838-7910
Novo Nordisk A/S
Participants with obesity with or without type 2 diabetes
SEMTOL 1.0
University Of Tartu
Overweight and obesity
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
Seoul National University Hospital
Food Addiction Tendency · Obesity · Overweight
Imaging in Semaglutide Study
The Cleveland Clinic
Type 2 Diabetes · BMI Greater Than 30
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
University of Arizona
Pancreatic Cancer · Colorectal Cancer · Hepatocellular Carcinoma
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
The Methodist Hospital Research Institute
Alzheimer Dementia (AD)
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
Biophytis
Muscle Wasting · Obesity & Overweight · Obesity
Free Fatty Acid Effects In Type 2 Diabetes
University of Ulster
Type 2 Diabetes · Cardiovascular Disease · Omega-3 Fatty Acids
Preoperative Semaglutide Prior to Radical Prostatectomy
Banner Health
Prostate Cancer
Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant
Vivani Medical, Inc
Obesity & Overweight
Effects of GLP-1 RAs on Human Lactation Outcomes
University of Colorado, Denver
Lactation · Weight Loss
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Obesity and Semaglutide in Type 1 Diabetes Therapy (OBES1TY): A Multicentre, Randomised, Double-Blinded, Placebo-Controlled, Investigator-Initiated Trial
Region Hovedstaden
Obesity defined by BMI equal to or higher than 30, Obesity defined by BMI equal to or higher than 27 and obesity-related diagnosis registered in the electronic patient journal such as: hypertension, hypercholesterolemia, dyslipidemia, micro albuminuria, ischemic heart disease, stroke, atherosclerosis or athrosis), Type 1 Diabetes
K9531-3107
Kailera Therapeutics Inc.
Obesity
An open-label, single-center, non-controlled pilot clinical trial to assess the efficacy of weekly semaglutide in combination with regular counselling sessions to reduce craving and use of chemsex associated drugs (CoSem4Chemsex) study.
Institute Of Tropical Medicine
Craving for and use of chemsex-related drugs
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
Gila Therapeutics, Inc.
Obesity & Overweight
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Terrestrial Bio, Inc.
Overweight and/or Obesity
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
Chinese University of Hong Kong
Intracerebral Hemorrhage
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
University of Colorado, Denver
Obesity/Therapy
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ohio State University
Obesity & Overweight · Diabetes (DM)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Novo Nordisk A/S
Obesity
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
Shanghai Jiao Tong University School of Medicine
Type 2 Diabetes · Obesity · Non-alcoholic Fatty Liver Disease
Semaglutide (Wegovy) Treatment for Trichotillomania
University of Chicago
Trichotillomania (Hair-Pulling Disorder) · Trichotillomania · Hair Pulling Disorder · Hair Pulling
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
Children's Hospital Los Angeles
Pediatric Obesity · Metabolic and Bariatric Surgery · Semaglutide
Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
Hallym University
Obesity · Metabolic Syndrome · Brown Adipose Tissue
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock
National University of Singapore
Aging · Obesity & Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
NN9490-8028
Novo Nordisk A/S
Participants with overweight or obesity, and type 2 diabetes
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Novo Nordisk A/S
Obesity · Type 2 Diabetes
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Novo Nordisk A/S
Obesity · Overweight · Diabetes Mellitus, Type 2
Weight Loss in Adults Using Semaglutide (Real-world Study)
Novo Nordisk A/S
Overweight · Obesity
A randomized, double-blind, placebo-controlled trial of semaglutide for reducing cannabis use in adults with cannabis use disorder
Region Hovedstaden
Cannabis dependence (Cannabis Use Disorder or CUD)
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
Emory University
Diabetes Mellitus, Type 2
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
Daewoong Pharmaceutical Co. LTD.
Obesity & Overweight · Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
First Affiliated Hospital of Wenzhou Medical University
Obesity-related Male Infertility
Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
Qilu Pharmaceutical Co., Ltd.
Type 2 Diabetes
GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity
China-Japan Friendship Hospital
Obesity
GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
Noom Inc.
Obesity & Overweight · Weight Loss · Preventative Health · Body Weight
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Baylor Research Institute
Chronic Kidney Disease · Type 2 Diabetes
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
Anders Fink-Jensen, MD, DMSci
Cannabis Use Disorder · Cannabis Use Disorders · Cannabis Abuse · Cannabis Dependence
Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
Eighth Affiliated Hospital, Sun Yat-sen University
Obesity Type 2 Diabetes Mellitus
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
NN9662-8160
Novo Nordisk A/S
type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
Ole Lander Svendsen
Foot Ulcer Due to Type 2 Diabetes Mellitus
CODIF-015
Bispebjerg Hospital
Type 2 diabetes, Diabetic foot ulcer
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
National and Kapodistrian University of Athens
Obesity (Disorder) · Anti-obesity Agents · Precision Medicine
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Vanderbilt University Medical Center
HIV · Alcohol · Smoking Cigarette · Cardiovascular Disease Prevention
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
Novo Nordisk A/S
Obesity
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
University of Florida
Endometrioid Endometrial Adenocarcinoma
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
William Marsh Rice University
GLP - 1 · Obesity & Overweight · Muscle Loss · Exercise Intervention
A Study of CS060380 Tablets in Patients With MASH and Obesity
Cascade Pharmaceuticals, Inc
Metabolic Dysfunction-associated Steatohepatitis (MASH) · Obesity
Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
Leiden University Medical Center
Aortic Stenosis · Heart Failure
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
The First Affiliated Hospital with Nanjing Medical University
Type 2 Diabetes · Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
Tri-Service General Hospital (TSGH)
Obesity and Metabolic Syndrome
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
Veru Inc.
Obesity & Overweight · Mobility Disability · HOMA-IR
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
Eccogene
Adult Obesity · Weight Management
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
Emma Svennberg
Atrial Fibrillation (AF) · Obesity & Overweight
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
GT Metabolic Solutions, Inc.
Obesity (Disorder) · Obesity & Overweight · Type 2 Diabetes (T2DM)
Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
Yale University
Alcohol Use Disorder · Weight Loss · Bariatric Surgery Patients
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
University of Texas Southwestern Medical Center
Mild Autonomous Cortisol Secretion (MACS) · Autonomous Cortisol Secretion (ACS) · Subclinical Cushing's · Mild Autonomous Cortisol Excess
REVERsal to normoglycemia by Treating PREDIABETES: the REVERT-PREDIABETES trial
Region Midtjylland
Coronary artery disease, Prediabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
Shanghai World Leader Pharmaceutical Co., Ltd.
Overweight · Obesity
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
Cambridge University Hospitals NHS Foundation Trust
Cardiovascular Diseases
Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
LMC Diabetes & Endocrinology Ltd.
Diabetes (DM) · Type 2 Diabetes · Obesity (Disorder)
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
University of Colorado, Denver
Menopause · Menopause Hot Flashes · Menopause Related Conditions · Cardiovascular
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Attikon Hospital
Dry Eye Disease (DED) · Diabete Mellitus · GLP-1 · Ocular Surface
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Glutide for Ending Methamphetamine
San Francisco Department of Public Health
Methamphetamine-dependence
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
University of Alberta
Chronic Kidney Disease in Type 2 Diabetes · Obesity & Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Semaglutide for Smoking Cessation in Patients With Diabetes
Ottawa Heart Institute Research Corporation
Diabetes Mellitus, Type 2 · Nicotine Addiction · Tobacco Dependence
A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
Novo Nordisk A/S
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Incretin Microdosing for Cardiometabolic Health in People With HIV
The University of Texas Health Science Center, Houston
Weight Gain
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
Brigham and Women's Hospital
Obesity · Overweight
A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
QuickSilver Scientific
Prediabetes / Type 2 Diabetes
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Novo Nordisk A/S
Diabetes Mellitus, Type 2
The Effect of Semaglutide on the Intestinal Flora in Obesity
Beijing Chao Yang Hospital
Obesity
Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
Institute of Liver and Biliary Sciences, India
Chronic Kidney Diseases · MAFLD
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
Methodist Health System
Polycystic Ovary Syndrome
Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
Mount Sinai Hospital, Canada
Obesity (Disorder) · Weight Change · Blood Pressure Monitoring · Appetite Regulation
A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
Peking University Third Hospital
Psoriasis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Brigham and Women's Hospital
Type 2 Diabetes · Overweight · ASCVD
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
Brigham and Women's Hospital
Type 2 Diabetes · Heart Failure
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Jinling Hospital, China
Short Bowel Syndrome (SBS) · Intestinal Failure
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme
University of Health Sciences, Algeria
Obesity Difficult Airway Airway Management · Obesity Adult Onset · Obesity and Cardiovascular Risk · Obesity Type 2 Diabetes Mellitus
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
Brigham and Women's Hospital
Type 2 Diabetes Mellitus · Obesity · Overweight
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Mayo Clinic
Bipolar I Disorder · Bipolar II Disorder · Schizo Affective Disorder · Obesity
Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
Fundacion Dexeus
Infertility · Obesity
Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled Trial
Santiago Dexeus Font Fundacio Privada
Infertility
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Yale University
Alcohol Use Disorder (AUD) · HIV
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Hospital Universitario Dr. Jose E. Gonzalez
Psoriasis (PsO) · Obesity & Overweight · Diabetes Mellitus - Type 2
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
The University of Texas Health Science Center, Houston
Cocaine Use Disorder
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Novo Nordisk A/S
Overweight · Obesity
A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
Halia Therapeutics, Inc.
Diabetes Mellitus, Type 2 · Obesity
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
University Health Network, Toronto
Kidney Transplant Recipient
Improved Treatment and Monitoring of Alzheimer's Disease
Rune Skovgaard Rasmussen
Alzheimer Disease (AD)
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Indiana University
Obesity
Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus
ProGen. Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Kailera
Obesity
Epicardial Cardiac Fat-CT (EPIC-CT)
Instituto Mexicano del Seguro Social
STEMI - ST Elevation Myocardial Infarction · Epicardial Fat
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Instituto Mexicano del Seguro Social
Acute Myocardial Infarction With ST Elevation
Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
Istanbul Galata University
Obesity
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
Fujian Shengdi Pharmaceutical Co., Ltd.
Obesity
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
The Cleveland Clinic
Liver Cirrhoses · Portal Hypertension Related to Cirrhosis · Severe Obesity · TIPS
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
Fudan University
Gastric Retention
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Novo Nordisk A/S
Type 2 Diabetes
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
Chinese University of Hong Kong
Psoriasis Arthritis
Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice
Prof. Dr. Martin Wabitsch
Monogenic Obesity
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients
San Raffaele Telematic University
Obesity & Overweight · Taste Alterations · Weight Loss · Eating Behavior Changes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
Unity Health Toronto
Kidney Disease, Chronic · Diabetes · Dialysis · End Stage Kidney Disease (ESRD)
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Steno Diabetes Center Copenhagen
Type 2 DM · Type 2 DM /Diabetic Nephropathy · Albuminuria
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
University of Virginia
Heart Failure Preserved Ejection Fraction · Epicardial Adipose Tissue
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
SHICAN
Universita Cattolica Del Sacro Cuore
type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
WEgovy Real World Assessment of Weight Loss in Korea
Novo Nordisk A/S
Obesity
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Novo Nordisk A/S
Obesity
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
City of Hope Medical Center
Prostate Carcinoma · Recurrent Prostate Carcinoma
SAFE-K
Region Midtjylland
Chronic kidney disease
SIGNAL - Body fluid proteome SIGnatures for persoNALised intervention to prevent cardiovascular and renal complications in diabetes
Steno Diabetes Center Copenhagen
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
2019-002274-31
Kobenhavns Universitet
Obesity
Semaglutide Treatment in Type 1 Diabetes
Nordsjaellands Hospital
Obesity in Diabetes · Obesity/Therapy · Type 1 Diabetes Mellitus (T1DM) · Insulin Sensitivity/Resistance
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
Taipei Veterans General Hospital, Taiwan
Glucagon-Like Peptide-1 Receptor Agonists · Type 2 Diabetes · Coronary Arterial Disease (CAD)
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
Mayo Clinic
Obesity
Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
Kristin Clemens
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
BP45703
F. Hoffmann-La Roche AG
Type 2 Diabetes Mellitus (T2D)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Oral Semaglutide in Patients With Alzheimer's Disease
Imperial College London
Alzheimer Disease
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Gan & Lee Pharmaceuticals.
Obesity/Overweight in Adult
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
Closed Loop Medicine
Obesity & Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of Semaglutide on Bone Health
The First Affiliated Hospital of Xiamen University
Osteoporosis · Osteoporosis Fracture · T2DM
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
Fudan University
Gastric Retention
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
Fudan University
Gastric Retention
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
Nordsjaellands Hospital
Major Depressive Disorder
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Nemours Children's Clinic
Polycystic Ovarian Syndrome in Adolescent Females · Obesity (Disorder)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
Federico II University
T2DM (Type 2 Diabetes Mellitus)
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
University Hospital, Gentofte, Copenhagen
Obesity &Amp; Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist
The University of Hong Kong
Osteoarthritis (OA) of the Knee
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
Guangdong Raynovent Biotech Co., Ltd
T2DM
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
Hoffmann-La Roche
Type 2 Diabetes Mellitus
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
Washington University School of Medicine
Obesity · Skeletal Muscle · Brain Connectivity
Comparison of Body Composition Changes With Weight Loss Interventions
Vanderbilt University Medical Center
Obesity
A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
Novo Nordisk A/S
Obesity
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
University of Maryland, Baltimore
Cocaine Use Disorder · HIV
J1R-MC-GZFD
Eli Lilly & Co.
Type 2 Diabetes
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Dasman Diabetes Institute
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
Hospital Italiano de Buenos Aires
Diabetes Mellitus
Rebalancing the Fat Content of the Heart and Muscles
University of Aberdeen
Diabetes Mellitus Type 2
Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
Shandong New Time Pharmaceutical Co., LTD
Type 2 Diabetes (T2DM)
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
Asian Institute Of Medical Sciences
Obesity · Weight Reduction · Cardiometabolic Risk Factors
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Hangzhou Sciwind Biosciences Co., Ltd.
Obesity · Weight Management
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
National Institute of Cardiology, Warsaw, Poland
Coronary Artery Disease · PreDiabetes
CSDS.IV/VIII/2023
Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
Coronary Heart Disease, Prediabetes, Coronary Atherosclerosis, Coronary Artery Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
BioPhenoT2D
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
BrightGene Bio-Medical Technology Co., Ltd.
Type 2 Diabetes (T2DM)
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
Hamilton Health Sciences Corporation
Prostate Cancer
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 1
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
RenJi Hospital
Acute Ischemic Stroke
24-h Energy Expenditure and Anti-obesity Medication
University of Pisa
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
NN6497-8316
Novo Nordisk A/S
Diabetes mellitus type 1
The GOAL study: GLP-1 receptor agonist treatment for Adolescents with Obesity secondary to Antipsychotic Medication - A feasibility study
Clinical Pharmacology, Department of
Adipositas
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
Actimed Therapeutics Ltd
Obesity · Muscle Loss
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
Shanghai East Hospital
Diabetes Mellitus, Type 2 · Nicotine Dependence, Cigarettes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Peter Rossing
Chronic Kidney Disease(CKD)
JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
McMaster University
Obesity (Disorder)
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Novo Nordisk A/S
Obesity
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
John Bauer
Obesity and Overweight · Obese Adolescents · Weight Management · Weight Loss
Probiotic Intervention on Body Weight
Chinese Academy of Sciences
Obesity · Homeostasis · Weight Loss · Probiotic Intervention
Protein Supplementation Intervention on Body Weight
Chinese Academy of Sciences
Obesity · Weight Loss · Protein Supplementation
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
Kafrelsheikh University
Heart Failure · Heart Valve Prosthesis
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
Adults With Simple Obesity
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company
Diabetes Mellitus · Insulin Sensitivity
Semaglutide for Helping Opioid Recovery
Brigham and Women's Hospital
Opioid Use Disorder
Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus
Second Affiliated Hospital of Guangzhou Medical University
Type 2 Diabetes
New Triple Therapy in Newly Diagnosed Type 2 Diabetes
Sun Yat-sen University
Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Fundación para la Investigación del Hospital Clínico de Valencia
Diabetes Mellitus Type 2
Is the glucagon-like peptide-1 receptor agonist semaglutide able to alleviate mood in patients with major depressive disorder and overweight or obesity? Sema-Mood.
Region Hovedstaden
Unipolar depression Overweight and obesity, Obesity and overweight
EPHIC-DIA2
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
Sheba Medical Center
Type 2 Diabetes Mellitus in Obese
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）
Innovent Biologics (Suzhou) Co. Ltd.
Overweight · Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
Mayo Clinic
Obesity · Menopause
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
Novo Nordisk A/S
Obesity
TRI CRF 23-05
Trinity College Dublin
Cardiovascular disorders: Hypertension and Obesity
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide
Ascletis Pharma (China) Co., Limited
Chronic Weight Management
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
University of Chicago
Overweight or Obesity · Atrial Fibrillation
NN9541-7841
Novo Nordisk A/S
Chronic Kidney Disease, with or without Type 2 diabetes, Obesity
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Marzieh Salehi
Spinal Cord Injuries · Type 2 Diabetes
Additive Benefits of Semaglutide for open-AngLe glaucoma – an Opportunity for Neuroprotection (ABSALON)
Rigshospitalet
Glaucoma
Tailoring Obesity Treatment Trial
Esbjerg Hospital - University Hospital of Southern Denmark
Obesity · Appetite Regulation · PreDiabetes
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre
Diabetes Type 1
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
Boehringer Ingelheim
Obesity
UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study
The United Bio-Technology (Hengqin) Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
Effect of Semaglutide in Patients With Psoriasis and Obesity
The University of Hong Kong
Psoriasis (PsO) · Obesity and Overweight
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
ETH Zurich
Obesity and Obesity-related Medical Conditions · Obesity and Overweight · Insulin Sensitivity/Resistance · Semaglutide
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
Washington University School of Medicine
Endometrial Hyperplasia
NOK0024 / Z2023097
Stichting Zuyderland Medisch Centrum
obesity
Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
University of Hull
Polycystic Ovary Syndrome
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Obesity
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
University of Colorado, Denver
Obesity; Drug
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity)
Vestfold Hospital Trust
Obesity
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Overweight or Obesity
D7261C00001
AstraZeneca AB
Type 2 Diabetes Mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of a Novel Precision Medicine Approach For Obesity
Mayo Clinic
Obesity
Semaglutide's Weight Loss Effects in Obesity
Beijing Chao Yang Hospital
Obesity
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
Lia Bally
Menopause · Type 2 Diabetes
NN9536-7752
Novo Nordisk A/S
Obesity
Tailored Exercise Training Study Among Adults With HFpEF
University of Texas Southwestern Medical Center
HFpEF - Heart Failure With Preserved Ejection Fraction · Diabetic Cardiomyopathies
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
Gan & Lee Pharmaceuticals.
Type 2 Diabetes Mellitus (T2DM)
17456
Universitair Medisch Centrum Groningen
Chronic Kidney Disease
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Novo Nordisk A/S
Obesity
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
Wei Hu
Acute Ischemic Stroke · Large Vessel Occlusion · Neuroprotective Drugs · Endovascular Treatment
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Polycystic Ovary Syndrome (PCOS) Women · Obesity
Study of Patients Being Treated With Anti-obesity Medication
Texas Tech University
Obesity and Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Ali Aminian
Obesity and Obesity-related Medical Conditions
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Mostafa Bahaa
Diabetes
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
University Hospital, Basel, Switzerland
Healthy Volunteer Study · HPA · Cortisol Deficiency · Adrenal Insufficiency
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
Brigham and Women's Hospital
Diabetes Mellitus, Type 2 · HFpEF - Heart Failure With Preserved Ejection Fraction
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Brigham and Women's Hospital
Diabetes Mellitus, Type 2 · HFpEF - Heart Failure With Preserved Ejection Fraction
GLP-1R Agonist Treatment for Opioid Use Disorder
Milton S. Hershey Medical Center
Opioid Use Disorder · Opioid Abuse and Addiction · Narcotic-Related Disorders · Substance-Related Disorders
Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
Zomagen Biosciences Ltd.
Obesity
Coronary Flow Reserve Changes After Semaglutide Treatment
Ekrem Bilal Karaayvaz
The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic Patients · Obesity &Amp; Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Obesity Control
Tirzepatide Impact Assessment Study
Texas Tech University
Obesity & Overweight · Cardiometabolic Health Indicators · Addiction · Eating Disorders
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
St Andrew's Healthcare
Obesity and Obesity-related Medical Conditions · Psychiatric Disorders
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Metabolic Associated Fatty Liver Disease · Metabolic Associated-dysfunction Steatohepatitis (MASH) · Obesity
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
Glostrup University Hospital, Copenhagen
Primary Open Angle Glaucoma (POAG) · Open-Angle Glaucoma · Glaucoma
Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Brigham and Women's Hospital
Type 2 Diabetes · Heart Failure
Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea
Shanghai Fengxian District Central Hospital
Sleep Apnea Syndrome (OSAS)
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.
China-Japan Friendship Hospital
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
MaryAnn Banerji
Type 2 Diabetes (T2DM)
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
Vivani Medical, Inc
Overweight and Obesity · Type2diabetes
HS-24-787
Camurus AB
Body weight management
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
AgelessRx
Longevity · GLP-1 · Geroscience · Aging
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
Novo Nordisk A/S
Overweight · Obesity · Atherosclerotic Cardiovascular Disease (ASCVD)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Lexaria Bioscience Corp.
Type2diabetes
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Novo Nordisk A/S
Chronic Kidney Disease
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
McGill University Health Centre/Research Institute of the McGill University Health Centre
Type 1 Diabetes · Diabetes Mellitus
A Study of BGM0504 in Participants with Type 2 Diabetes
BrightGene Bio-Medical Technology Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea
Novo Nordisk A/S
Obesity and Overweight
A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
Amgen
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
AgelessRx
Longevity · Quality of Life · Mood · Inflammation
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Brigham and Women's Hospital
Type 2 Diabetes
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
Popular Medical College Hospital
Obesity · Type 2 Diabetes Mellitus (T2DM)
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
University of California, Davis
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd.
Type 2 Diabetes
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Obesity
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
Brigham and Women's Hospital
Diabetes Mellitus, Type 2
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Brigham and Women's Hospital
Diabetes Mellitus, Type 2
Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
Brigham and Women's Hospital
Diabetes Mellitus, Type 2
STABIL-NOR study
Helse Bergen HF
Metabolic control in antipsychotic-using patients
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
Novo Nordisk A/S
Healthy Volunteers Type 2 Diabetes
TOLEDDO
Centre Hospitalier Universitaire De Dijon
"double diabetes"
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
University of Colorado, Denver
Obesity · Adolescent Obesity · Body-Weight Trajectory · Weight Loss Trajectory
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
Ciusss de L'Est de l'Île de Montréal
Gastric Retention
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
AstraZeneca
Diabetes Mellitus, Type 2
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
University Medical Centre Ljubljana
Type 2 Diabetes Mellitus (T2DM)
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
Brigham and Women's Hospital
Type 2 Diabetes · Overweight · Cardiovascular (CV) Risk
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Boehringer Ingelheim
Obesity
14040047
Boehringer Ingelheim International GmbH
No targeted indication. Male and female subjects with obesity.
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Novo Nordisk A/S
Type 2 Diabetes
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Western University, Canada
Obesity · Chronic Kidney Disease
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Type 2 Diabetes
Semaglutide in Treatment of Obesity
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Weight Management
Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
Rigshospitalet, Denmark
Hyperglycemia · Renal Transplant Complication Primary Non-Function · Diabetes
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Novo Nordisk A/S
Obesity
Prevention of Progression of Prediabetes, Obesity and CV Risk
The University of Texas Health Science Center at San Antonio
Pre-Diabetes · Weight, Body · Cardiovascular Diseases
PROTECT
Rigshospitalet
Mucositis and systemical inflammation, which is a treatment-related complication after treatment with high-dose chemotherapy
Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation
Rigshospitalet
Hyperglycaemia after renal transplantation
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
University of Sao Paulo General Hospital
Diabetic Patients · Acute Myocardial Infarction
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Skye Bioscience, Inc.
Obesity
Semaglutide in Auto-HSCT
Klaus Gottlob Müller
Intestinal Mucositis · Inflammation · Chemotherapeutic Toxicity
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
Bispebjerg Hospital
Diabetes Mellitus, Type 2 · Kidney Disease, Chronic
The Effects of Semaglutide on Body Composition and Performance in Military Personnel
United States Army Research Institute of Environmental Medicine
Obesity
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
Bostal Drug Delivery Co., Ltd
Diabetes Mellitus, Type 2
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
The Cleveland Clinic
Diabetes Mellitus, Type 2 · Obesity · Gastroparesis
2022-501392-81-00
Stichting Rijnstate Ziekenhuis
Atrial fibrillation, Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
DUTCH Weight Control in Atrial Fibrillation Study
Rijnstate Hospital
Atrial Fibrillation · Obesity · Weight Loss
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
Shanghai Jiao Tong University School of Medicine
Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Obesity · Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
Yale University
Diabetes type1 · Obesity
Mechanisms of Semaglutide Therapy in Heart Failure Patients
University Medical Centre Ljubljana
Heart Failure · Obesity
Impact of Semaglutide on Tobacco Use and Related Health Behaviors
University of Oklahoma
Tobacco Use
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Steno Diabetes Center Copenhagen
Cardiovascular Diseases · Heart Failure · Type 1 Diabetes · Kidney Failure
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
University Hospital Tuebingen
Normal Weight · Overweight and Obesity · Insulin Sensitivity · Insulin Resistance
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
Novo Nordisk A/S
Obesity
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
Neurogastrx, Inc.
Overweight and Obesity · Healthy
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
The First Affiliated Hospital with Nanjing Medical University
Type 2 Diabetes · Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Vanderbilt University Medical Center
Type 1 Diabetes
Special Use - Results Surveillance on Long-term Use With Wegovy®
Novo Nordisk A/S
Obesity
SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®
Hospices Civils de Lyon
Obesity · Bariatric Surgery · Binge Eating Disorder · Syndromic Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
Odense University Hospital
Type 2 Diabetes · Osteopenia
Semaglutide and Cognition in Healthy Volunteers
University of Oxford
Cognitive Change
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Novo Nordisk A/S
Alcohol-related Liver Disease
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
Imperial College London
Steroid-Induced Diabetes · Steroid Induced Hyperglycemia
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
Western Galilee Hospital-Nahariya
Diabetes Mellitus · Kidney Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Capital Medical University
Idiopathic Intracranial Hypertension
Semaglutide 2.4mg for Low Responders After Bariatric Surgery
Zuyderland Medisch Centrum
Obesity · Obesity, Morbid · Weight Gain
Body Surface Gastric Mapping in Patients on Semaglutide
University of Western Sydney
Semaglutide-Induced Gastric Motility · Gastroparesis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
Jens D Hove, MD,PHD
Heart Failure With Reduced Ejection Fraction · Obesity · Weight Loss · Chronic Heart Failure
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
Veru Inc.
Muscle Loss · Obesity
Semaglutide for Post-Smoking Cessation Weight Management
The University of Texas Health Science Center, Houston
Obesity · Overweight · Cigarette Smoking
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
University of Washington
Diabetic Kidney Disease · Type 1 Diabetes
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Obesity; Drug
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
Novo Nordisk A/S
Chronic Kidney Disease · Type 2 Diabetes · Obesity
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Chengdu Brilliant Pharmaceutical Co., Ltd.
Type 2 Diabetes Mellitus
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Novo Nordisk A/S
Type 2 Diabetes
FIT-HF trial
Region Hovedstaden
Obesity and Heart Failure with reduced Ejection Fracition
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Novo Nordisk A/S
Type 2 Diabetes
Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)
National Health Research Institutes, Taiwan
Metabolic Syndrome
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
Regeneron Pharmaceuticals
Obesity
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
Massachusetts General Hospital
Genetic Predisposition · Metabolic Diseases · Type 2 Diabetes
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
University Medical Center, Kazakhstan
Metabolic Syndrome
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Innovent Biologics (Suzhou) Co. Ltd.
Type 2 Diabetes · Obesity
Subcutaneous Semaglutide in Systemic Scleroderma
Second Xiangya Hospital of Central South University
Scleroderma, Systemic · Fibrosis · Semaglutide
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Novo Nordisk A/S
Obesity
Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Type 2 Diabetes Mellitus
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
Novo Nordisk A/S
Obesity
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
University of Virginia
NAFLD
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Eli Lilly and Company
Diabetes Mellitus, Type 2
Semaglutide and Physical Activity for Obesity and Multimorbidity
Hvidovre University Hospital
Obesity Morbid · Multimorbidity · Obesity
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
University Hospital Sestre Milosrdnice
Type 2 Diabetes · Overweight · Disordered Eating Behaviors
Impact GLP-1 Agonists Following Bariatric
University of Missouri-Columbia
Morbid Obesity · Metabolic Syndrome · Diabetes Mellitus · Hypertension
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
COMMETS- Combination MCI Metabolic Syndrome
Rutgers, The State University of New Jersey
Alzheimer Disease · Mild Cognitive Impairment · Metabolic Syndrome
Feasibility of Semaglutide in Advanced Lung Disease
University of Pennsylvania
Obesity · Interstitial Lung Disease · Chronic Obstructive Pulmonary Disease · Sarcoidosis, Pulmonary
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
Merck Sharp & Dohme LLC
Healthy
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Novo Nordisk A/S
Type 2 Diabetes
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
University of Washington
Diabetes Mellitus, Type 2 · Stroke (CVA) or Transient Ischemic Attack
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
University of Colorado, Denver
Alcohol Use Disorder
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
China-Japan Friendship Hospital
Diabetes Mellitus · Cardiovascular Diseases · Cerebrovascular Disease
Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
Ministry of Health, Saudi Arabia
Type 1 Diabetes
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
Goztepe Prof Dr Suleyman Yalcın City Hospital
Steatosis of Liver · Metabolic Liver Injury · Obesity · Overweight
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
University of Palermo
Diabetes Mellitus Type 2
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
China-Japan Friendship Hospital
Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels
Hillel Yaffe Medical Center
Metabolic Disease
Effects of extensive Weight loss on Insulin resistance and Lipid-kinetics in people with obesity and fatty liver Disease
Region Midtjylland
Obesity, Non-alcoholic Fatty Liver Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
DIALYSIS-TIR Study
University of Texas Southwestern Medical Center
Type 2 Diabetes · End Stage Renal Disease on Dialysis
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
Novo Nordisk A/S
Obesity
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
University of Colorado, Denver
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries · Obese
Semaglutide and Intestinal Iron Absorption
University Hospital Dubrava
Diabetes Mellitus Type 2 · Iron Absorption
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
Brigham and Women's Hospital
Overweight and Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Aalborg University Hospital
Diabetes Mellitus, Type 2
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
Medanta, The Medicity, India
Liver Transplant; Complications · Diabete Mellitus
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
University Health Network, Toronto
Kidney Transplant Recipients
Semaglutide Therapy for Alcohol Reduction (STAR)
National Institute on Drug Abuse (NIDA)
Addiction · Alcohol Use Disorder
Semaglutide in CFRD
University of Minnesota
Cystic Fibrosis · Cystic Fibrosis-related Diabetes
GENETIC VARIABILITY TO GLP1 TREATMENT
GENGE
Type 2 Diabetes · Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
Dr Adnan Agha
Non-Alcoholic Fatty Liver Disease · Non-alcoholic Steatohepatitis · Type 2 Diabetes · Liver Fat
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
Novo Nordisk A/S
Healthy Participants
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Novo Nordisk A/S
Type 2 Diabetes Mellitus
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Eli Lilly and Company
Type 2 Diabetes
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Type 2 Diabetes
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Cardenal Herrera University
Chronic Kidney Disease stage3 · Chronic Kidney Disease stage4 · Chronic Kidney Disease Stage 1 · Chronic Kidney Disease Stage 2
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
Novo Nordisk A/S
Overweight · Obesity
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven
Glucose Intolerance After a Recent History of Gestational Diabetes
S66967
UZ Leuven
prediabetes
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
RenJi Hospital
Obesity · Chronic Kidney Diseases
MK-6024-013
Merck Sharp & Dohme LLC
Non-alcoholic steatohepatitis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Study of BGM0504 in Chinese Patients With Type 2 Diabetes
BrightGene Bio-Medical Technology Co., Ltd.
Type 2 Diabetes
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Novo Nordisk A/S
Obesity or Overweight
A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
Novo Nordisk A/S
Healthy Participants
A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
Gan and Lee Pharmaceuticals, USA
Type 2 Diabetes
NN9924-4977
Novo Nordisk A/S
Type 2 Diabetes
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Diabetes Mellitus, Type 2
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
Nanjing First Hospital, Nanjing Medical University
Diabetes
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Iain Bressendorff
Diabetic Kidney Disease
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
Chinese University of Hong Kong
Stroke · Stroke, Acute · Stroke, Ischemic · Brain Diseases
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
University of California, San Diego
Fibrosis, Liver · Type 2 Diabetes Mellitus in Obese · Non-Alcoholic Fatty Liver Disease
NN6535-7519
Novo Nordisk A/S
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Yale University
Type 2 Diabetes Mellitus · Impaired Glucose Tolerance · Non-Alcoholic Fatty Liver Disease · Obesity, Childhood
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
Qilu Pharmaceutical Co., Ltd.
Type 2 Diabetes
Semaglutide Therapy for Alcohol Reduction - Tulsa
Oklahoma State University Center for Health Sciences
Alcohol Use Disorder
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
Novo Nordisk A/S
Obesity
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
Novo Nordisk A/S
Pregnancy · Obesity · Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
NN9536-4512
Novo Nordisk A/S
Obesity and overweight
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
CorEvitas
Metabolic Health
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
Geropharm
Pharmacokinetics · Safety Issues · Bioequivalence
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
Merck Sharp & Dohme LLC
Non-alcoholic Fatty Liver Disease · Fatty Liver, Nonalcoholic · NAFLD · Nonalcoholic Fatty Liver Disease
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
University of Colorado, Denver
Diabetes Mellitus, Type 1
A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
Novo Nordisk A/S
Alzheimers Disease
Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
Hospital Israelita Albert Einstein
Pneumonia, Aspiration · Anesthesia
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Psychiatric Centre Rigshospitalet
Alcohol Abuse · Alcohol Addiction · Alcohol Dependence · Alcohol Use Disorder
Does the Glucagon-like Peptide 1 (GLP-1) receptor agonist semaglutide reduce alcohol intake in patients with Alcohol Use Disorder and comorbid obesity?
Region Hovedstaden
Alcohol Use Disorder
Retrospective Analysis for Patients With Metabolic Syndrome
Second Affiliated Hospital, Zhejiang University, School of Medicine
Metabolic Syndrome
Anti-obesity Pharmacotherapy and Inflammation
Louisiana State University Health Sciences Center in New Orleans
Obesity
A Study of HS-20094 in T2DM Participants
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
Novo Nordisk A/S
Overweight · Obesity
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
Peking University First Hospital
PCOS (Polycystic Ovary Syndrome) · Semaglutide
Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
University of Banja Luka
Psoriasis Vulgaris · Diabetes Type 2
Semaglutide to Reduce Atrial Fibrillation Burden
San Francisco Veterans Affairs Medical Center
Atrial Fibrillation · Obesity · Overweight
A comparison between patient obesity self-injection education using artificial-intelligence powered "clinicians" and humans
University Hospital Galway
Overweight and Obesity
Semaglutide and Vascular Regeneration
Canadian Medical and Surgical Knowledge Translation Research Group
Atherosclerosis · Cardiovascular Diseases · Diabetes Mellitus, Type 2 · Obesity
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
Eli Lilly and Company
Obesity · Overweight
Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity
S.LAB (SOLOWAYS)
Overweight and Obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
Aarhus University Hospital
Acute Ischemic Stroke
The safety and efficacy of acute subcutaneous administration of semaglutide in non-diabetic patients with acute ischemic stroke: a multicentre, phase 2, prospective, randomized, open-label, blinded endpoint trial (ASSET)
Aarhus University Hospital
Ischemic Stroke
ADJUnct Semaglutide Treatment in Type 1 Diabetes
Viral N. Shah
Type 1 Diabetes · Obesity
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
Boehringer Ingelheim
Healthy · Obesity
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
Novo Nordisk A/S
Obesity or Overweight
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
The University of Texas Health Science Center at San Antonio
Aging · Diabetes Mellitus, Type 2 · PreDiabetes · Overweight and Obesity
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
University of Yaounde 1
Obesity and Overweight · Appetite Regulation
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Georgios Papadakis
Klinefelter Syndrome
A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants
Novo Nordisk A/S
Healthy Participants
A Study of Cardiovascular Events iN Diabetes Plus
University of Oxford
Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations
Novo Nordisk A/S
Non-alcoholic Steatohepatitis
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Novo Nordisk A/S
Cardiovascular Disease
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
RenJi Hospital
Metformin · Obesity, Abdominal · Diabetes Mellitus, Type 2 · Abdominal Fat
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Semaglutide in Nonalcoholic Fatty Liver Disease
Zagazig University
Non-alcoholic Fatty Liver Disease
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Second Affiliated Hospital of Nanchang University
Type 2 Diabetes Mellitus (T2DM) · Semaglutide · Caloric Restriction
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
Karolinska Institutet
Type 2 Diabetes
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
Novo Nordisk A/S
Overweight · Obesity · Type 2 Diabetes Mellitus
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
University of California, Los Angeles
Obesity
O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes: A Randomized Open Intervention Study That Compares Empagliflozin, Pioglitazone and Semaglutide (DiaSpax)
Karolinska University Hospital
Diabetes type 2
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Novo Nordisk A/S
Obesity
A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
Pfizer
Obesity
A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
Novo Nordisk A/S
Diabetes Mellitus, Type 2 · Healthy Participants
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
Per Løgstrup Poulsen
Type 2 Diabetes · Cardiovascular Diseases
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
INTEN-CT
Aarhus University Hospital, Odense University Hospital
Type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
Novo Nordisk A/S
Obesity
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
Novo Nordisk A/S
Obesity · Diabetes Mellitus, Type 2
Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Type 2 Diabetes
Latino Semaglutide Study
Loma Linda University
Obesity · Obesity; Drug · Overweight or Obesity · Weight Loss
Comparison of Body Weight Change Through Different Smeglutide Administration Methods
Huashan Hospital
Weight Change, Body
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Brigham and Women's Hospital
Diabetes
Oral delivery of semaglutide to the colon for improved absorption
BDD Pharma Ltd
Oral delivery of semaglutide to the colon
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Eli Lilly and Company
Obesity · Obese · Overweight or Obesity
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Novo Nordisk A/S
Obesity
Semaglutide 2.4 mg in Patients With Poor Weight-loss
University College, London
Obesity · Diabetes · Metabolic Syndrome
Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
Pfizer
Diabetes Mellitus · Obesity
Semaglutide vs Sitagliptin
University Health Network, Toronto
Liver Transplant; Complications · Diabetes Mellitus · NASH - Nonalcoholic Steatohepatitis · NAFLD
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Vanderbilt University Medical Center
Asthma
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
Novo Nordisk A/S
Overweight · Obesity
Effects of Semaglutide on Nicotine Intake
University of North Carolina, Chapel Hill
Tobacco Use Disorder · Nicotine Addiction
Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
Axel Brandes
Atrial Fibrillation · Overweight and Obesity
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
S62015
UZ Leuven
Patients with Crohn's disease undergoing surgery and having at least one risk factor for postoperative recurrence of the disease.
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
Mayo Clinic
Cardiomyopathy · Heart Failure With Preserved Ejection Fraction (HFpEF) · Obesity
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
Rigmor Højland Jensen
Idiopathic Intracranial Hypertension · Intracranial Pressure · Obesity · Pseudotumor Cerebri Syndrome
Semaglutide for Alcohol Use Disorder
University of North Carolina, Chapel Hill
Alcohol Use Disorder · Cigarette Smoking
Glucagone Like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as treatment of Idiopathic Intracranial Hypertension
Rigshospitalet
Idiopathic Intracranial Hypertension
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Semaglutide Use in Elderly Obese Patients
State University of New York at Buffalo
Obesity · Aging
Genetics of the Acute Response to Oral Semaglutide
Medical University of Bialystok
PreDiabetes · Prediabetic State · Obesity
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
Novo Nordisk A/S
Diabetes Mellitus, Type 2 · Obesity
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Novo Nordisk A/S
Obesity
Does semaglutide change the build up of Alzheimer's disease proteins in people at risk?
Imperial College London
Alzheimer's disease
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
University of Pennsylvania
Obesity
A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Diabetes Mellitus, Type 2
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
Centre Hospitalier Universitaire Dijon
Double Diabetes
Efficacy of Oral Semaglutide in Overweight or Obesity
Asian Institute of Gastroenterology, India
Obesity · Weight Loss
A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
Rehman Medical Institute - RMI
Type 2 Diabetes
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
University College Dublin
Obesity · HIV-1-infection
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
Novo Nordisk A/S
Healthy Volunteers
A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
Novo Nordisk A/S
Diabetes Mellitus, Type 2
NN9917-4751
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Semaglutide_2019
University College Dublin
HIV & Obesity
Young Adults With Early-onset Obesity Treated With Semaglutide
Signe Torekov
Obesity, Adolescent
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Chinese University of Hong Kong
Cerebral Small Vessel Disease
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Centre for Addiction and Mental Health
Schizophrenia Spectrum Disorders
Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
University of Roma La Sapienza
Obesity and Obesity-related Medical Conditions
Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
University Medical Centre Ljubljana
Diabetes Mellitus, Type 2 · Atherosclerosis
Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Can semaglutide, a GLP-1 agonist, which mimics a hormone that regulates appetite and blood sugar levels, help non-obese people achieve and maintain weight loss
Sharon Giese, MD
Weight loss and the benefits
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Pharmacogenetics of Response to GLP1R Agonists
University of Maryland, Baltimore
Obesity · Diabetes Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Lifestyle Counseling and Medication for Adolescent Weight Management
University of Minnesota
Obesity, Childhood
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
University Medical Center Groningen
Obesity · Albuminuria
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
Aga Khan University
Diabetes Mellitus, Type 2 · Weight Change, Body
Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
University of Erlangen-Nürnberg Medical School
Diabetes Mellitus, Type 2
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
Attikon Hospital
Diabetes Type 2
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)
University College Dublin
Metabolic Disease · Obesity & Overweight
Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
Kirsi Pietiläinen
Type2 Diabetes
A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity
Novo Nordisk A/S
Obesity
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
Novo Nordisk A/S
Healthy Volunteers · Type 2 Diabetes
Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
Sansum Diabetes Research Institute
Diabetes Mellitus, Type 2 · Glucose Metabolism Disorders (Including Diabetes Mellitus)
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
Asger Lund, MD
Type 2 Diabetes · Obesity
A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
Novo Nordisk A/S
Healthy Volunteers (Diabetes Mellitus, Type 2)
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
Woman's
Pre Diabetes · Postpartum Disorder
Semaglutide Use in Acute Pulmonary Embolism
Imperial College London
Pulmonary Embolism
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
Jan Frystyk
Schizophrenia · Prediabetic State
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
University of Colorado, Denver
Type 2 Diabetes · Chronic Inflammation · Intestinal Permeability
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
General and Teaching Hospital Celje
Endothelial Dysfunction · Diabetes Mellitus, Type 1 · Biomarkers · Endothelial Progenitor Cells
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Sit Less, Interact and Move More (SLIMM) 2 Study
Srinvasan Beddhu
Chronic Kidney Diseases · Obesity
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
The University of Texas Health Science Center, Houston
PreDiabetes
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
Novo Nordisk A/S
Overweight and Obesity
A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
Novo Nordisk A/S
Healthy Volunteers · High Blood Cholesterol Levels · Type 2 Diabetes
Effect Of Semaglutide In Coronary Atheroma Plaque
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Atheroscleroses, Coronary
Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder
University Health Network, Toronto
Major Depressive Disorder
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
Novo Nordisk A/S
Obesity
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
University of Nottingham
Type 2 Diabetes Mellitus in Obese
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
Novo Nordisk A/S
Obesity · Overweight
Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
Vladimír Džavík
Covid19 · Myocardial Injury
A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
Novo Nordisk A/S
Obesity
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Anders Fink-Jensen, MD, DMSci
Metabolic Disturbance · Schizophrenia · Type 2 Diabetes · Clozapine
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
Foundation for Atlanta Veterans Education and Research, Inc.
Type 2 Diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
Novo Nordisk A/S
Non-alcoholic Steatohepatitis
NN9500-4656
Novo Nordisk A/S
Non-alcoholic steatohepatitis (NASH)
Treatment of GLP-1 for Diabetic Bariatric Patients
Geisinger Clinic
Diabetes Mellitus, Type 2
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences
Nonalcoholic Steatohepatitis
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
Merck Sharp & Dohme LLC
Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital
Cardiovascular Events · Type2 Diabetes · Renal Disease
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
Geisinger Clinic
CKD · Diabetic Kidney Disease · Type 2 Diabetes Mellitus in Obese · Obesity
A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
Novo Nordisk A/S
Obesity
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
Novo Nordisk A/S
Obesity & Overweight
Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data
Brigham and Women's Hospital
Diabetes Mellitus, Type 2
The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
American University of Beirut Medical Center
Obesity · Weight Loss
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
Novo Nordisk A/S
Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2
The Effect of Semaglutide on Pituitary Function
University of Tartu
Healthy
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Novo Nordisk A/S
Early Alzheimer's Disease
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Novo Nordisk A/S
Early Alzheimer´s Disease
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men
Novo Nordisk A/S
Healthy Volunteers Type 2 Diabetes
NN6535-4730
Novo Nordisk A/S
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
NN6535-4725
Novo Nordisk A/S
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
Novo Nordisk A/S
Diabetes Mellitus, Type 2 · Chronic Kidney Disease
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Novo Nordisk A/S
Non-alcoholic Steatohepatitis
NN9931-4553
Novo Nordisk A/S
Non-alcoholic steatohepatitis (NASH)
Combined Active Treatment in Type 2 Diabetes With NASH
German Diabetes Center
Type 2 Diabetes · Non-alcoholic Steatohepatitis (NASH) · Non-alcoholic Fatty Liver Disease (NAFLD)
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
Morten Frost
Osteopenia
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
Novo Nordisk A/S
Obesity
Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections · Non-Alcoholic Fatty Liver Disease
GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
Yale University
Obesity
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
The Cleveland Clinic
Type 2 Diabetes
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
Novo Nordisk A/S
Overweight · Obesity · Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
NN9924-4437
Novo Nordisk A/S
Type 2 diabetes
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2 · Peripheral Arterial Disease
Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
Novo Nordisk A/S
Diabetes Mellitus, Type 2
The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
University Medical Centre Ljubljana
Type 2 Diabetes Mellitus · Obesity · Functional Hypogonadism
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
Region Skane
Type2 Diabetes
A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
AstraZeneca
Type 2 Diabetes Mellitus · Chronic Kidney Diseases
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
Novo Nordisk A/S
Healthy Volunteers Type 2 Diabetes
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
Boehringer Ingelheim
Diabetes Mellitus, Type 2
SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
16-week Flexible vs. 8-week Semaglutide Titration
Tel-Aviv Sourasky Medical Center
Diabetes type2
First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
Novo Nordisk A/S
Healthy Volunteers · Overweight · Obesity · Diabetes Mellitus, Type 2
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
Novo Nordisk A/S
Overweight · Obesity
A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
Novo Nordisk A/S
Pregnancy · Obesity · Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
Novo Nordisk A/S
Healthy Volunteers · Overweight · Obesity
Real-world Health Outcomes in Canadian Patients Using Semaglutide
LMC Diabetes & Endocrinology Ltd.
Type 2 Diabetes
A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
Exercise and GLP-1 RA on Insulin Secretion
University of Copenhagen
Type 2 Diabetes
Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
Novo Nordisk A/S
Healthy Volunteers · Diabetes Mellitus, Type 2 · Overweight · Obesity
A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens
Novo Nordisk A/S
Healthy Volunteers · Diabetes Mellitus, Type 2
The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity
University Medical Centre Ljubljana
PCOS · Semaglutide · Taste, Altered · Tongue Tissue Transcriptome
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
Steno Diabetes Center Copenhagen
Type 2 Diabetes With Renal Manifestations
A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
Novo Nordisk A/S
Healthy Volunteers Diabetes Mellitus, Type 2 · Healthy Volunteers Overweight · Healthy Volunteers Obesity
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese
Novo Nordisk A/S
Healthy Volunteers · Diabetes Mellitus, Type 2
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
Novo Nordisk A/S
Healthy Volunteers · Type 2 Diabetes
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
Novo Nordisk A/S
Healthy Volunteers · Type 2 Diabetes
Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
University of Miami
Epicardial Fat
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
Sabyasachi Sen
Diabetes Mellitus, Type 2
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Eli Lilly and Company
Type 2 Diabetes
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences
Nonalcoholic Steatohepatitis
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Non-Alcoholic Steatohepatitis · Non-Alcoholic Fatty Liver Disease
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company
Diabetes Mellitus, Type 2
A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
Novo Nordisk A/S
Healthy Volunteers Diabetes Mellitus, Type 2 · Healthy Volunteers Overweight · Healthy Volunteers Obesity
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Novo Nordisk A/S
Non-alcoholic Steatohepatitis
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Case Western Reserve University
HIV/AIDS · Lipohypertrophy · Obesity
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
University of Colorado, Denver
PCOS · Adolescent Obesity · NAFLD
NN9535-4352
Novo Nordisk A/S
While it is well-established that long-term good glycaemic control will reduce the risk of diabetic retinopathy development and progression, intensification of glycaemic control has also been associated with an initial worsening of diabetic retinopathy. This phenomenon is known as “early worsening”. The rationale of this trial is to establish the long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (T2D) using validated and standardised ophthalmic assessments. This trial is a post-authorisation safety study (PASS) conducted as a commitment to the European Medicines Agency
Triple Therapy in T1DM
State University of New York at Buffalo
Type 1 Diabetes Mellitus
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Semaglutide Treatment On Coronary Progression
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Type 2 Diabetes · Coronary Artery Disease
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
Novo Nordisk A/S
Overweight · Obesity
STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
Novo Nordisk A/S
Diabetes Mellitus, Type 2
GLP1R in Parkinson's Disease
Oslo University Hospital
Parkinson Disease
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Eli Lilly and Company
Diabetes Mellitus, Type 2
Once Weekly GLP-1 in Persons With Spinal Cord Injury
James J. Peters Veterans Affairs Medical Center
Spinal Cord Injuries · Insulin Resistance · Pre Diabetes · Obesity
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
Novo Nordisk A/S
Obesity and Overweight
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Novo Nordisk A/S
Overweight · Obesity
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
Novo Nordisk A/S
Overweight · Obesity
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
Novo Nordisk A/S
Obesity · Overweight
A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
Novo Nordisk A/S
Diabetes Mellitus, Type 2
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
Novo Nordisk A/S
Metabolism and Nutrition Disorders · Overweight or Obesity
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Overweight or Obesity
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
Novo Nordisk A/S
Obesity · Overweight
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
Novo Nordisk A/S
Diabetes Mellitus, Type 2
A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
Novo Nordisk A/S
Hepatobiliary Disorders · Non-alcoholic Fatty Liver Disease
A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
Novo Nordisk A/S
Hepatobiliary Disorders · Non-alcoholic Steatohepatitis
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
Novo Nordisk A/S
Diabetes · Healthy
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
Novo Nordisk A/S
Metabolism and Nutrition Disorder · Obesity
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
Novo Nordisk A/S
Diabetes · Healthy
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide
Novo Nordisk A/S
Diabetes · Healthy
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Hepatic Impaired
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
Novo Nordisk A/S
Diabetes · Metabolism and Nutrition Disorder · Obesity
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects
Novo Nordisk A/S
Diabetes · Healthy
Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Healthy
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes
Novo Nordisk A/S
Diabetes · Healthy
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Healthy
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
Effect of Renal Impairment on the Pharmacokinetics of NN9535
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Renal Impairment
Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
Novo Nordisk A/S
Diabetes · Healthy
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2
Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
Novo Nordisk A/S
Diabetes · Diabetes Mellitus, Type 2 · Healthy
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
West China Hospital
Alzheimer Disease · Diabetes Mellitus Type 2 · Obesity & Overweight
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
Shanghai Zhongshan Hospital
Non-diabetic Obesity
49RC23_0307
Centre Hospitalier Universitaire D'Angers
Craniopharyngioma
Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation
Rigshospitalet
Hyperglycaemia after renal transplantation
Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?
Psykiatrisk Center Kobenhavn
Schizophrenia
IKEM-ISS-02
Institut Klinicke A Experimentalni Mediciny
Obesity
ARMYDA - 10
Azienda Ospedaliero-Universitaria Maggiore Della Carita
non-ST-elevation myocardial infarction (NSTEMI); unstable angina, diabetes mellitus
Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascular Disease: the SEMA-PLAT Study
Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali
Diabetes Mellitus, Cardiovascular disease, Overweight (BMI ≥27 kg/m²), Obesity (BMI≥30kg/m2)
Weight management with orismilast alone or in combination with s.c. semaglutide (WELOSITI)
Gentofte Hospital
obesity
PI24/01356
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
PI24/01356
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Type 2 diabetes
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
MSGLP/GAMS
Comenius University Bratislava
Patients with confirmed multiple sclerosis (MS), with worse prognosis given the higher disease activity, in productive age between 18 and 60 years, with EDSS<5, who at the time of investigation are on baseline therapy of the disease for at least 3 months
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
SEM-BEAT
UZ Leuven
obesity
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
STABLE-GLP1
Universita' Degli Studi Di Napoli Federico II
Type 2 diabetes mellitus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
RAPHAEL
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre
obstructive sleep apnea
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Semaglutide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.